New EAU 2026 research finds prostate cancer screening has little impact on quality of life or anxiety in men. Learn more ...
Prostate cancer is the most commonly diagnosed cancer in the UK. But screening is not universal, and charities are divided over whether it should be extended. What do those living with the disease ...
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research. The findings are ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA treatment ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
First results of the PRIMARY2 randomized phase III trial support consideration of PSMA PET/CT in diagnostic work-up ...
Abstract: Prostate cancer is a prevalent malignancy in men, often diagnosed using magnetic resonance imaging (MRI). Accurate segmentation of prostate MRI is crucial for early cancer diagnosis, yet the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results